Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: ARTERIAL OCCLUSIVE DISEASES - DRUG THERAPY , . Treffer: 17
2017
Jud, P; Hafner, F; Gary, T; Ghanim, L; Lipp, R; Brodmann, M
Intra-arterial thrombolysis of digital artery occlusions in a patient with polycythemia vera.
Vasa. 2017; 46(1):64-66
Doi: 10.1024/0301-1526/a000586
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2015
Singer, OC; Berkefeld, J; Nolte, CH; Bohner, G; Haring, HP; Trenkler, J; Gröschel, K; Müller-Forell, W; Niederkorn, K; Deutschmann, H; Neumann-Haefelin, T; Hohmann, C; Bussmeyer, M; Mpotsaris, A; Stoll, A; Bormann, A; Brenck, J; Schlamann, MU; Jander, S; Turowski, B; Petzold, GC; Urbach, H; Liebeskind, DS; ENDOSTROKE Study Group
Mechanical recanalization in basilar artery occlusion: the ENDOSTROKE study.
Ann Neurol. 2015; 77(3):415-424
Doi: 10.1002/ana.24336
Web of Science
PubMed
FullText
FullText_MUG
2011
Olschewski, A
Blocking potassium channels: a new principle for treating restenosis?
Cardiovasc Res. 2011; 89(2):255-257
Doi: 10.1093/cvr/cvq388
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2005
van Royen, N; Schirmer, SH; Atasever, B; Behrens, CY; Ubbink, D; Buschmann, EE; Voskuil, M; Bot, P; Hoefer, I; Schlingemann, RO; Biemond, BJ; Tijssen, JG; Bode, C; Schaper, W; Oskam, J; Legemate, DA; Piek, JJ; Buschmann, I
START Trial: a pilot study on STimulation of ARTeriogenesis using subcutaneous application of granulocyte-macrophage colony-stimulating factor as a new treatment for peripheral vascular disease.
Circulation. 2005; 112(7): 1040-1046.
Doi: 10.1161/CIRCULATIONAHA.104.529552
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2003
van Royen, N; Piek, JJ; Legemate, DA; Schaper, W; Oskam, J; Atasever, B; Voskuil, M; Ubbink, D; Schirmer, SH; Buschmann, I; Bode, C; Buschmann, EE
Design of the START-trial: STimulation of ARTeriogenesis using subcutaneous application of GM-CSF as a new treatment for peripheral vascular disease. A randomized, double-blind, placebo-controlled trial.
Vasc Med. 2003; 8(3):191-196
Doi: 10.1191/1358863x03vm496oa
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2002
Roller, RE; Dorr, A; Ulrich, S; Pilger, E
Effect of aspirin treatment in patients with peripheral arterial disease monitored with the platelet function analyzer PFA-100.
Blood Coagul Fibrinolysis. 2002; 13(4):277-281
Doi: 10.1097/00001721-200206000-00001
Web of Science
PubMed
FullText
FullText_MUG
2001
Buschmann, IR; Hoefer, IE; van Royen, N; Katzer, E; Braun-Dulleaus, R; Heil, M; Kostin, S; Bode, C; Schaper, W
GM-CSF: a strong arteriogenic factor acting by amplification of monocyte function.
Atherosclerosis. 2001; 159(2):343-356
Doi: 10.1016/S0021-9150(01)00637-2
Web of Science
PubMed
FullText
FullText_MUG
Roller, RE; Renner, W; Tischler, R; Pilger, E; Schnedl, WJ
Vascular endothelial growth factor in plasma of patients undergoing peripheral angioplasty.
Thromb Haemost. 2001; 85(6):1119-1120
Doi: 10.1055/s-0037-1615975
[Poster]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
1994
Pilger, E; Decrinis, M; Stark, G; Koch, G; Obernosterer, A; Tischler, R; Lafer, M; Doder, A
Thrombolytic treatment and balloon angioplasty in chronic occlusion of the aortic bifurcation.
Ann Intern Med. 1994; 120(1):40-44
Doi: 10.7326/0003-4819-120-1-199401010-00007
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Tischler, R; Decrinis, M; Skursky-Roller, R
Can vasomotion be modified by vasoactive substances or hemodilution?
Acta Med Austriaca. 1994; 21(5):133-136
Web of Science
PubMed
1993
Decrinis, M; Pilger, E; Stark, G; Lafer, M; Obernosterer, A; Lammer, J
A simplified procedure for intra-arterial thrombolysis with tissue-type plasminogen activator in peripheral arterial occlusive disease: primary and long-term results.
Eur Heart J. 1993; 14(3):297-305
Doi: 10.1093/eurheartj/14.3.297
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
1991
Pallapies, D; Peskar, BA
Substances with vasoactive effects mediated by the prostaglandin system.
Vasa Suppl. 1991; 33(4): 75-76.
PubMed
1988
Fitscha, P; Simmet, T; Peskar, BA; Reuter, H; Sinzinger, H; Rogatti, W; Tilsner, V
Fibrinolytic activity, thrombocyte function and pharmacokinetics during intra-arterial or intravenous prostaglandin E1 infusion in patients with chronic arterial occlusive disease
Wien Klin Wochenschr. 1988; 100(14):477-481
Web of Science
PubMed
Google Scholar
Pilger, E; Bertuch, H; Stark, G; Hönigl, K
Prostaglandin E1 in decreased arterial perfusion
WIEN KLIN WOCHENSCHR. 1988; 100(14): 490-495.
Web of Science
PubMed
Sinzinger, H; Peskar, BA
Prostaglandin E1 between pathomechanism and therapy
Wien Klin Wochenschr. 1988; 100(14): 469-470.
Web of Science
PubMed
1986
Pilger, E; Lammer, J; Bertuch, H; Steiner, H
Intraarterial fibrinolysis: in vitro and prospective clinical evaluation of three thrombolytic agents.
Radiology. 1986; 161(3):597-599
Doi: 10.1148/radiology.161.3.3786705
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
1985
Sailer, S; Pilger, E
Fibrinolytic therapy of peripheral arterial occlusive disease
WIEN MED WOCHENSCHR. 1985; 135(15-16): 393-399.
Web of Science
PubMed